←
National Kidney Foundation19,402 posts
National Kidney Foundation avatar

National Kidney Foundation

@nkf

We’re fighting to eliminate preventable kidney disease, accelerate innovation, and dismantle structural inequities in kidney care. Join our fight.

◷ Joined July 2007▧ 3,710 Photos and videos
National Kidney Foundation avatar
National Kidney Foundation@nkf·31 Dec 2025

This clinical research study is evaluating an investigational treatment option to potentially help manage and slow the progression of immunoglobulin A nephropathy (IgAN), or Berger’s disease. Learn more: bit.ly/4oN0ojP

Post attachment
National Kidney Foundation avatar
National Kidney Foundation@nkf·31 Oct 2025

Patients living with Immunoglobulin A nephropathy (IgAN), or Berger’s disease, may be eligible for a clinical research study that may help improve kidney function and slow the progression of IgAN. Learn more: bit.ly/3H23xMj

Post attachment
National Kidney Foundation avatar
National Kidney Foundation@nkf·23 Oct 2025

Join us virtually as we highlight real-world implementation data from NKF’s flagship CKDintercept program, a national strategy to improve CKD testing, diagnosis, and management in the primary care setting. RSVP: bit.ly/4niApQz

Post attachment
NKF Advocacy avatar
⟳ National Kidney Foundation retweeted
NKF Advocacy@NKF_Advocacy·19 Aug 2025

TODAY is Kidney Heroes Giving Day! Today we honor KIDNEY HEROES and the life-changing difference they make for people with kidney disease. From donors and recipients to doctors and family members, anyone can be a kidney hero. Honor your hero: bit.ly/44W83Wq

Post attachment
National Kidney Foundation avatar
National Kidney Foundation@nkf·5 Aug 2025

Currently, there aren’t enough donated kidneys to meet the growing demand. But xenotransplantation could help change that. kidney.org/news-stories/clin…

National Kidney Foundation avatar
National Kidney Foundation@nkf·5 Jul 2025

This clinical research study is evaluating an investigational treatment option to potentially help manage and slow the progression of immunoglobulin A nephropathy (IgAN), or Berger’s disease. Learn more: bit.ly/3H23xMj

Post attachment
National Kidney Foundation avatar
National Kidney Foundation@nkf·4 Jul 2025

RESET-SLE™ is a phase 1/2 clinical trial being conducted to evaluate the effects of an investigational cell therapy, CABA-201, in patients with active lupus nephritis (LN) or active lupus (SLE) without renal involvement. Learn more about the study at reset-sle-trial.com.

Post attachment